Leda Leoncini

Prognosis of Acute Myeloid Leukemia in the General Population: Data from Southern Switzerland

Erika Lerch, Vittoria Espeli, Emanuele Zucca et al. · Tumori Journal · 2009 · 33 citations

Medicine, Hematology, Oncology +14

A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function

Marco Siano, Erika Lerch, Laura Negretti et al. · Clinical Cancer Research · 2008 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)

Jakob Passweg, Thomas Pabst, Sabine Blum et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 24 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias

Paula Fernández, Max Solenthaler, Olivier Spertini et al. · PLoS ONE · 2012 · 19 citations · Full text

Life Sciences, Hematology, Molecular Biology +17